SEB Asset Management AB Buys New Position in DaVita Inc. $DVA

Posted by George Bondi on Jul 25th, 2026

SEB Asset Management AB purchased a new position in shares of DaVita Inc. (NYSE:DVA – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,279 shares of the company’s stock, valued at approximately $658,000.

Other hedge funds have also made changes to their positions in the company. Root Financial Partners LLC boosted its stake in shares of DaVita by 128.0% in the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after purchasing an additional 105 shares during the period. Caitlin John LLC purchased a new stake in DaVita during the 4th quarter worth approximately $34,000. Sankala Group LLC purchased a new stake in DaVita during the 4th quarter worth approximately $39,000. Canada Pension Plan Investment Board acquired a new stake in DaVita during the 2nd quarter worth approximately $43,000. Finally, Kestra Advisory Services LLC purchased a new position in DaVita in the 4th quarter valued at approximately $45,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

NYSE DVA opened at $235.46 on Friday. The company has a fifty day moving average of $213.62 and a two-hundred day moving average of $168.71. The company has a market capitalization of $15.12 billion, a PE ratio of 21.84, a P/E/G ratio of 0.77 and a beta of 0.88. DaVita Inc. has a 1 year low of $101.00 and a 1 year high of $239.64.

DaVita (NYSE:DVA – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.33 by $0.54. The business had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.00 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, research analysts expect that DaVita Inc. will post 15.07 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Truist Financial increased their price objective on DaVita from $205.00 to $250.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft raised DaVita from a “hold” rating to a “buy” rating and increased their price target for the company from $126.00 to $220.00 in a research report on Wednesday, May 6th. UBS Group boosted their price objective on DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, July 10th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of DaVita in a report on Monday, June 8th. Finally, Zacks Research cut shares of DaVita from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Two equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $216.50.

Check Out Our Latest Analysis on DaVita

Insider Buying and Selling

In related news, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the completion of the sale, the insider owned 109,194 shares in the company, valued at $22,756,029.60. This represents a 12.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Joel Ackerman sold 51,471 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the transaction, the chief financial officer directly owned 132,434 shares in the company, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.90% of the stock is currently owned by insiders.

DaVita Company Profile

(Free Report)

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.